摘要
血栓栓塞性疾病,主要包括冠状动脉疾病、脑血管疾病、末稍动静脉疾病。血栓是导致病残和死亡的主要原因,发病率仍在继续上升。因此,临床上非常重视溶栓药物的治疗。本文重点介绍尿激酶溶栓机制、临床应用范围,治疗方法、禁忌证、和副作用等。并对该溶栓剂的应用进行评价。
Thrombo-embolism diseases were mostly coronary occlusion, cerebrovascu-lar thrombosis and peripheral arterial or venous thrombosis. The main cause of savage and death was thrombolism, the disease incidence is continually rising. Thrombolytic therapy is closely concentrated in clinic. We mainly introduce the mechanism of throm-bolysis by urokinase, clinical utility, therapeutic method, adverse reaction and contraindication. The clinical utility of the throrabolytic agent is evaluated.
出处
《新药与临床》
CSCD
北大核心
1991年第3期183-186,共4页
关键词
血栓形成
尿激酶类
溶栓疗法
urokinase/therapeutic use
coronary disease/drug therapy
thrombosis/ drug therapy
